Amongst women who experience recurrent pregnancy loss, around 20% test positive for a specific antibody that targets the mother's own body. A Kobe...

New therapy for women with recurrent pregnancy loss caused due to own antibodies,hasincreasedlive birth rates from 50% to 87% and reduced pregnancy...

Recurrent pregnancy loss occurs in women who have lost two or more pregnancies for unknown reasons. Dr. Kenji Tanimura and his team at Kobe...

Low-dose aspirin or heparin significantly improves live birth rates and reduces complications in women with recurrent pregnancy loss.

A groundbreaking study has unveiled a critical issue of therapeutic inertia in treating women with medlinkmultiple sclerosis/medlink (MS),...

What is the MENA region? MENA is the acronym for “Middle East and North Africa”, regularly used in academic and business writings. It refers...

In the months after the U.S. Supreme Court struck down the constitutional right to an abortion, there was a spike in the number of women seeking...

New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...

medlinkProstaglandin/medlink receptors are responsible for successful embryo implantation, and new research from Kumamoto University has revealed

Construction worker planning. (iStock) A new study by Greenline Insights has revealed that if passed, Washington’s Initiative 2117 could result in...